Biological agents in kidney transplantation: belatacept is entering the field (Q37781355)

23 August 2017

title

Biological agents in kidney transplantation: belatacept is entering the field (English)

1 reference

Isabelle Cardeau-Desangles

23 August 2017

main subject

kidney transplantation

1 reference

based on heuristic

inferred from title

author

series ordinal

4

object named as

Isabelle Cardeau-Desangles

1 reference

23 August 2017

5

Lionel Rostaing

1 reference

23 August 2017

2

Nassim Kamar

1 reference

23 August 2017

1

Hugo Wéclawiak

1 reference

23 August 2017

author name string

Abdoulattif Ould-Mohamed

series ordinal

3

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

Expert Opinion on Biological Therapy

23 August 2017

published in

1 reference

23 August 2017

volume

10

1 reference

23 August 2017

issue

10

1 reference

23 August 2017

page(s)

1501-1508

1 reference

Trends in kidney transplantation over the past decade

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Recent developments in kidney transplantation--a critical assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Modern renal transplantation: present challenges and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Immunosuppression in renal transplantation: some aspects for the modern era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Kidney transplantation: the ideal immunosuppression regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

New immunosuppressive protocols with the advent of novel biological drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Cancer incidence and risk factors after solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

The natural history of chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Reviewing the evidence for de novo immunosuppression with sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

New approaches to de novo immunosuppression and steroid elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Immunosuppression and tumor development in organ transplant recipients: the emerging dualistic role of rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Minimizing the risk of posttransplant malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

The spectrum of antibody-mediated renal allograft injury: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Control of anti-donor antibody production post-transplantation: conventional and novel immunosuppressive therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Development of non-donor-specific HLA antibodies after kidney transplantation: frequency and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Deciphering antibody-mediated rejection: new insights into mechanisms and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

The immunological synapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

CTLA-4-Ig regulates tryptophan catabolism in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Abatacept for rheumatoid arthritis: a Cochrane systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Costimulation blockade in autoimmunity and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Costimulation blockade with belatacept in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Post-transplant renal function in the first year predicts long-term kidney transplant survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Evolution of endpoints for renal transplant outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Renal function as a predictor of long-term graft survival in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

When ligand becomes receptor--tolerance via B7 signaling on DCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.514901

10.1517/14712598.2010.514901

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference